The Revised International Prognostic Scoring System (IPSS-R) is a risk-stratification tool used in myelodysplastic syndromes (MDS) to estimate prognosis and guide treatment intensity.
Revised International Prognostic Scoring System (IPSS-R) for MDS
Calculator for Healthcare Professionals
The IPSS-R is a prognostic tool for patients with myelodysplastic syndromes (MDS). It incorporates five prognostic factors: cytogenetics, bone marrow blast percentage, hemoglobin, platelet count, and absolute neutrophil count. This calculator helps determine the risk category which correlates with overall survival and risk of transformation to acute myeloid leukemia (AML).
